Home › NDC Lookup › RxCUI directory › RxCUI 2604775

Hypromellose 3 MG/ML / povidone 5 MG/ML Ophthalmic Solution — RxCUI 2604775

Name: Hypromellose 3 MG/ML / povidone 5 MG/ML Ophthalmic Solution (RxCUI 2604775)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2604775 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2604775

Official nameHypromellose 3 MG/ML / povidone 5 MG/ML Ophthalmic Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ashypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution

FDA products mapped3

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Hypromellose 3 MG/ML / povidone 5 MG/ML Ophthalm... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Hypromellose 3 MG/ML / povidone 5 MG/ML Ophthalmic Solution RxCUI 2604775 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Hypromellose 27334 IN
- Povidone 8610 IN
- Hypromellose / povidone 2604772 MIN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Hypromellose / povidone Ophthalmic Solution 2604774 SCDF
- Hypromellose / povidone Ophthalmic Product 2604773 SCDG
- Ophthalmic Solution 7670 DF
- Ophthalmic Product 1151135 DFG
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Hypromellose 3 MG/ML 358710 SCDC
- Povidone 5 MG/ML 2531300 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Hypromellose 3 MG/ML SCDC · 358710
Povidone 5 MG/ML SCDC · 2531300
Hypromellose / povidone Ophthalmic Solution SCDF · 2604774
Hypromellose / povidone Ophthalmic Product SCDG · 2604773

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2604775 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
10742-8140-01	1 BOTTLE, DROPPER in 1 CARTON (10742-8140-1) / 18 mL in 1 B...	Rohto Sun and Sport	The Mentholatum Company	2022-07-01
10742-8459-01	1 BOTTLE, DISPENSING in 1 CARTON (10742-8459-1) / 18 mL in...	Rohto Dual Light Relief	The Mentholatum Company	2024-05-30
66613-8459-01	1 BOTTLE, DISPENSING in 1 CARTON (66613-8459-1) / 18 mL in...	Rohto Dual Light Relief	Rohto Pharmaceutical Co., Ltd.	2024-05-30

Observed labelers: The Mentholatum Company (2) · Rohto Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.